胸主动脉腔内修复术中左锁骨下动脉血运重建效果的系统评价与荟萃分析
该系统评价与荟萃分析纳入16项队列研究共2591例患者,比较胸主动脉腔内修复术(TEVAR)中覆盖左锁骨下动脉(LSA)时行与不行LSA血运重建的效果。结果显示LSA血运重建组围术期卒中率和脊髓缺血率显著低于未血运重建组,围术期死亡率和截瘫率两组无显著差异。作者建议对TEVAR中LSA覆盖的患者推荐行LSA血运重建,并指出需要高质量随机对照试验进一步验证结论。
要点
- LSA血运重建与较低的围术期卒中率相关(RR 0.61;95%CI 0.45-0.82;I²=20%)。
- LSA血运重建与较低的围术期脊髓缺血率相关(RR 0.59;95%CI 0.39-0.90;I²=0)。
- 围术期死亡率(RR 0.86;95%CI 0.60-1.21)和截瘫率(RR 0.81;95%CI 0.45-1.44)两组无显著差异。
核心结论
- LSA血运重建与显著降低的围术期卒中和脊髓缺血率相关。
- 作者建议对TEVAR中LSA覆盖的患者推荐行LSA血运重建。
- 需要高质量随机对照试验进一步验证结论。
研究设计与样本
- 系统评价与荟萃分析,检索PubMed、Embase和Cochrane Library,纳入随机对照试验和队列研究。
- 纳入16项队列研究,共2591例患者。
- 纳入研究的平均得分为7.56。
- 采用Cochrane偏倚风险工具和Newcastle-Ottawa量表分别评价随机对照试验和队列研究的方法学质量。
- 二分类结局以相对危险度(RR)及95%置信区间(CI)表示;I²>50%时采用随机效应模型合并,否则采用固定效应模型。
主要发现
- 纳入患者的围术期卒中率为6.8%(n=176/2591)。
- LSA血运重建组与未血运重建组的围术期卒中率分别为5.4%和7.8%。
- 与未行LSA血运重建相比,LSA血运重建组围术期卒中率显著更低(RR 0.61;95%CI 0.45-0.82;I²=20%)。
- 与未行LSA血运重建相比,LSA血运重建组围术期脊髓缺血率显著更低(RR 0.59;95%CI 0.39-0.90;I²=0)。
- LSA血运重建组与未血运重建组围术期死亡率(RR 0.86;95%CI 0.60-1.21;I²=35%)和围术期截瘫率(RR 0.81;95%CI 0.45-1.44;I²=17%)无显著差异。
临床怎么用
- 作者建议对TEVAR中LSA覆盖的患者推荐行LSA血运重建。
- 作者指出需要高质量随机对照试验进一步验证结论。
局限性
- 需要高质量随机对照试验进一步验证结论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE/BACKGROUND: Thoracic endovascular aortic repair (TEVAR) is an emerging therapy for thoracic aortic pathologies. However, the role of left subclavian artery (LSA) revascularisation in patients with LSA coverage in TEVAR has not been established. A systematic review and meta-analysis was done to investigate the effect of LSA revascularisation in TEVAR when the LSA was covered. METHODS: PubMed, Embase, and the Cochrane Library were searched to find relevant randomised controlled trials (RCTs) and cohort studies. The Cochrane Risk of Bias Tool and Newcastle-Ottawa Scale was used to evaluate the methodological quality of RCTs and cohort studies respectively. Relative risks (RRs) with 95% confidence intervals (CIs) were calculated to express differences for dichotomous outcomes. Random effects models were used to combine outcomes for studies with I2 > 50%; otherwise, fixed effects models were used. Subgroup analyses and sensitivity analyses were performed to further validate the results. RESULTS: Sixteen cohort studies with a total of 2591 patients were included in this systematic review and meta-analysis. The average score of the included studies was 7.56. Of the included patients, the peri-operative stroke rate was 6.8% (n = 176/2591). The peri-operative stroke rates of the with and without LSA revascularisation groups were 5.4% and 7.8%, respectively. Compared with no LSA revascularisation, patients with LSA revascularisation had a significantly lower peri-operative stroke rate (RR 0.61; 95% CI 0.45-0.82; I2 = 20%) and peri-operative spinal cord ischaemia (SCI) rate (RR 0.59; 95% CI 0.39-0.90; I2 = 0). No significant difference was found between the with and without LSA revascularisation groups with respect to peri-operative mortality (RR 0.86; 95% CI 0.60-1.21; I2 = 35%) and peri-operative paraplegia (RR 0.81; 95% CI 0.45-1.44; I2 = 17%). CONCLUSION: The results of this review reveal that LSA revascularisation was associated with significantly lower peri-operative stroke and SCI rates. LSA revascularisation should be recommended for patients with LSA coverage in TEVAR. High quality RCTs are needed to further validate the conclusion.
引用
- Huang Q, Chen XM, Yang H, et al. Effect of Left Subclavian Artery Revascularisation in Thoracic Endovascular Aortic Repair: A Systematic Review and Meta-analysis. Eur J Vasc Endovasc Surg. 2018. PMID: 30122331. doi:10.1016/j.ejvs.2018.07.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。